{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-015893","form_type":"8-K/A","ticker":null,"cik":"0001476963","company_name":"Scorpius Holdings, Inc.","filed_at":"2023-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.033499+00:00","generated_at":"2026-06-10T11:57:50.931502+00:00","sec_items":["5.02","2.05","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NightHawk Biosciences cuts 13 employees (14% workforce) in restructuring, refocuses on CDMO","bullets":["Board approved restructuring plan on Sept 18, 2023 to shed non-core assets and reduce costs.","Workforce reduction of 13 R&D employees; expects $0.2M-$0.3M in charges in Q3 2023.","Annual compensation savings estimated at $1.8M from the workforce reduction.","Company will refocus resources on Scorpius Biomanufacturing (CDMO) for growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-015893","json":"https://secwatch.observer/filing/0001558370-23-015893.json","markdown":"https://secwatch.observer/filing/0001558370-23-015893.md","text":"https://secwatch.observer/filing/0001558370-23-015893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/0001558370-23-015893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/nhwk-20230919x8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T11:57:50.931502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c365ddf255cd2ef88fa68592d36321e369f060b","claim":"Scorpius Holdings, Inc. announced a restructuring with charges of approximately $0.2 million to $0.3 million affecting research and development efforts (approximately 13 employees).","evidence_excerpt":"research and development efforts. The Company expects to substantially complete the employee reduction immediately and estimates that it will incur a total of approximately $0.2 million to $0.3 million in charges in connection with the workforce reduction, all of which is expected to be incurred in the third quarter of 2023. These charges consist primarily of","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1476963/000155837023015893/0001558370-23-015893-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $0.2 million to $0.3 million"},{"label":"Affected area","value":"research and development efforts"},{"label":"Headcount","value":"approximately 13 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}